Author: SpOvum team

Renowned MIT Professor Visits SpOvum TechnologiesJuly 20, 2024

SpOvum was invited to German delegation program at IIScApril 18, 2024

SpOvum featured in a newspaper article about Mane Hospital's LifeNu IVF centerAugust 2, 2023

Bulk stiffness and recovery time - a measure of development of mouse embryosAugust 2, 2023

SpOvum’s brief interaction with the Oasis teamNovember 29, 2022

RoboICSI is recognised at the Medicall Innovation awards 2021December 18, 2021

Introducing SpOvum’s ARTGPT™ Chatbot: Your 24/7 ART and Andrology ExpertSeptember 11, 2024

Introducing SpOvum’s RIWB – The Most Advanced ICSI workbench

Renowned MIT Professor Visits SpOvum TechnologiesJuly 20, 2024

SpOvum was invited to German delegation program at IIScApril 18, 2024

SpOvum featured in a newspaper article about Mane Hospital's LifeNu IVF centerAugust 2, 2023

Bulk stiffness and recovery time - a measure of development of mouse embryosAugust 2, 2023

SpOvum’s brief interaction with the Oasis teamNovember 29, 2022

RoboICSI is recognised at the Medicall Innovation awards 2021December 18, 2021

Introducing SpOvum’s ARTGPT™ Chatbot: Your 24/7 ART and Andrology ExpertSeptember 11, 2024

SpOvum featured in a newspaper article about Mane Hospital’s LifeNu IVF center

An article in a Kannada newspaper was published on the importance of Mane Hospital’s LifeNu IVF center at Bagalkote City in northern Karnataka. The state-of-the-art technology enabled by SpOvum Technologies is much appreciated.

Here is the English Translation of the article

In 2018, Mane Multispecialty Hospital started an IVF center called LifeNu IVF center with all facilities for the first time in Bagalkot district. This is saving the time and money of many women who were going to different places for infertility treatment. From 2022 at Mane Hospital, in collaboration with SpOvum Technologies Company, the hospital has implemented quality maintenance technology at all stages of treatment through sensors. All treatments for infertility are available, including state-of-the-art ICSI technology treatment at affordable rates.
Due to this, not only people who were going to different cities for IVF treatment from many parts of North Karnataka like Koppala, Gadag, Vijayapur, and Belgaum are getting treatment at Dr. Mane Hospital’s LifeNu IVF center in Bagalkot, but also Dr. Vaishali has examples of couples from Bengaluru who came for the treatment and got children.

Renowned MIT Professor Visits SpOvum TechnologiesJuly 20, 2024

SpOvum was invited to German delegation program at IIScApril 18, 2024

Bulk stiffness and recovery time - a measure of development of mouse embryosAugust 2, 2023

SpOvum’s brief interaction with the Oasis teamNovember 29, 2022

RoboICSI is recognised at the Medicall Innovation awards 2021December 18, 2021

Introducing SpOvum’s ARTGPT™ Chatbot: Your 24/7 ART and Andrology ExpertSeptember 11, 2024

Bulk stiffness and recovery time – a measure of development of mouse embryos

Understanding the onset of embryonic arrest by studying the morphology of the embryos at different stages of their development is a relatively well-understood subject. The qualitative nature of the study makes it difficult to determine and quantify the causes behind the arrest. For successful embryonic development, it is essential to know, non-destructively, and the developmental viability of the embryos at a particular stage.

We investigate the bulk stiffness and recovery time as the viability quantifiers for grading or classifying embryos at the two-cell stage or after the formation of the first cleavage. A simple cantilever beam-based experimental procedure is established to investigate two-cell mouse embryos in two distinct orientations.

Bulk stiffness measurement varies with the embryo’s orientation and deformation. A good quality two-cell embryo shows a significant decrease in stiffness ratio with the deformation. Also, the embryo’s recovery time after releasing deformation may indicate a quality-dependent correlation.

Our study concludes that the bulk stiffness measurements in the two principal orientations, their ratio, and recovery time correlate with the underlying morphology of two-cell stage mouse embryos.

Here is the link for the full paper

https://jrhm.org/bulk-stiffness-and-recovery-time-a-measure-of-development-of-mouse-embryos/#F3

Renowned MIT Professor Visits SpOvum TechnologiesJuly 20, 2024

SpOvum was invited to German delegation program at IIScApril 18, 2024

SpOvum featured in a newspaper article about Mane Hospital's LifeNu IVF centerAugust 2, 2023

SpOvum’s brief interaction with the Oasis teamNovember 29, 2022

RoboICSI is recognised at the Medicall Innovation awards 2021December 18, 2021

Introducing SpOvum’s ARTGPT™ Chatbot: Your 24/7 ART and Andrology ExpertSeptember 11, 2024

DYU’s Little Baby Clinic

Happy to share that @spovumtechnologies has successfully collaborated with DYU Women and Childcare, Bangalore. Dr Prashant Gowda and Dr Jyothi Bandi are the prime movers of this hospital and their hospital hosts truly best-in-class facilities including the smARTIVF platform of SpOvum. DYU also takes pride in providing the best quality treatment for patients. DYU brings world-class to Bangalore! If you know anyone in and around this place you may spread the word. Thank you. DYU Women and Healthcare 1098, 14th Main Rd, Sector 3, HSR Layout, Bengaluru, Karnataka 560102 Contact: 080 4865 5556 /8050404040 Visit: https://www.dyuhealthcare.com/

Renowned MIT Professor Visits SpOvum TechnologiesJuly 20, 2024

SpOvum was invited to German delegation program at IIScApril 18, 2024

SpOvum featured in a newspaper article about Mane Hospital's LifeNu IVF centerAugust 2, 2023

Bulk stiffness and recovery time - a measure of development of mouse embryosAugust 2, 2023

SpOvum’s brief interaction with the Oasis teamNovember 29, 2022

RoboICSI is recognised at the Medicall Innovation awards 2021December 18, 2021

Introducing SpOvum’s ARTGPT™ Chatbot: Your 24/7 ART and Andrology ExpertSeptember 11, 2024

DYU – CME focused on Fertility and Women health ManagementDYU –

Renowned MIT Professor Visits SpOvum TechnologiesJuly 20, 2024

SpOvum was invited to German delegation program at IIScApril 18, 2024

SpOvum featured in a newspaper article about Mane Hospital's LifeNu IVF centerAugust 2, 2023

Bulk stiffness and recovery time - a measure of development of mouse embryosAugust 2, 2023

SpOvum’s brief interaction with the Oasis teamNovember 29, 2022

RoboICSI is recognised at the Medicall Innovation awards 2021December 18, 2021

Introducing SpOvum’s ARTGPT™ Chatbot: Your 24/7 ART and Andrology ExpertSeptember 11, 2024

Dr. Keshav Malhotra visits SpOvum

Dr. Keshav Malhotra MBBS. MCE holds a Masters’s degree in Clinical Embryology from Monash university Australia and is one of the few ESHRE-certified Clinical Embryologists from INDIA. He is the Lab Director of Rainbow IVF and now the Director of Malhotra Embryology Training Academy. Dr. Malhotra is the Co-chair of SIG Embryology for ASPIRE (Asia Pacific Initiative on Reproduction), and he is also on the executive board of ISAR(Indian Society of Assisted Reproduction) and ISPAT(Indian Society for Prenatal Diagnosis and Therapy). He has worked on Key projects pertaining to Embryology in India like the Occupational Standard for Embryologists (Healthcare Sector Skill Council India-2018) and the ISAR – Embryology Consensus 2019. He was recognized as Budding Embryologist of the Year by Economic Times INDIA -2019.

SpOvum^® got an opportunity to present its product portfolio to Dr. Keshav Malhotra, who visited SpOvum on 16th Dec 2022. He was fascinated by the RoboICSI workbench especially the one-click sperm immobilization feature of the RoboICSI workbench. Dr. Keshav was really excited when he tried out using the button-based controller and the one-click immobilization feature by himself.

Dr. Keshav Malhotra with Founder Directors of SpOvum

Dr. Keshav appreciated the stiffness estimation experiments on mouse embryos and the vision of applying the observations and their insights in the embryo monitoring system using the AI and ML of SpOvum.

He had some wonderful questions and a few good suggestions and was appreciative of SpOvum’s initiative in bringing innovations to the A.R.T. space through Robotics, Automation, and AI.

From left to right: Kishor, Santosh, Dr. Keshav Malhotra, Ramnath, and Kunal

One-click immobilization feature of the RoboICSI workbench displayed on the screen

Renowned MIT Professor Visits SpOvum TechnologiesJuly 20, 2024

SpOvum was invited to German delegation program at IIScApril 18, 2024

SpOvum featured in a newspaper article about Mane Hospital's LifeNu IVF centerAugust 2, 2023

Bulk stiffness and recovery time - a measure of development of mouse embryosAugust 2, 2023

SpOvum’s brief interaction with the Oasis teamNovember 29, 2022

RoboICSI is recognised at the Medicall Innovation awards 2021December 18, 2021

Introducing SpOvum’s ARTGPT™ Chatbot: Your 24/7 ART and Andrology ExpertSeptember 11, 2024

Demystifying Misconceptions about Infertility and conception using ART

World Health Organization (WHO) defines Infertility as Failure to achieve pregnancy after 12 months or more of regular unprotected sexual intercourse.

Here are some of the misconceptions about Infertility.

Myth 1: Treatment for Infertility is complex and expensive
It depends upon the condition of the patient. Depending upon the degree of the complexity of the situation different procedures like Ovulation Induction (OI), Intra Uterine Insemination (IUI), and Invitro fertilization (IVF) are available. The procedures need not be complex and expensive. Except for the case of IVF, others are out-patient treatments

Myth 2: Infertility is due to a female’s inability
On the contrary, males contribute significantly to infertility[1].

Myth 3: Infertility treatment assures success
Depending upon several aspects the success rate is estimated to be about 40% or more[2]

Myth 4: Infertility treatment is affordable only to the Rich
Indian medical eco-system is making conscious efforts in ensuring that the treatment is accessible and affordable without compromising on quality.

Myth 5: Infertility treatment can be taken at any age
While it seems to be true age plays a significant role in achieving success. The odds of success improve if one takes it at an earlier age.[3]

Let’s collaborate…

If you have questions or if you want to be a part of this myth-busting venture about infertility and conception using ART, you can reach out to contact@spovum.com or send a message on 9513646022

“If you or anyone you know need help in and around Bagalkote reach out to Mane Hospital’s LifeNu IVF Center. It is quite accessible and affordable. It is situated very close to both the Railway station as well the Bus Stand of Bagalkote. LifeNu in collaboration with SpOvum intends to bring the best in class ART technology to its patients!”
– LifeNu IVF Center, Mane Hospital

References:

Kumar N, Singh AK. Trends of male factor infertility, an important cause of infertility: A review of literature. J Hum Reprod Sci. 2015 Oct-Dec;8(4):191-6. doi: 10.4103/0974-1208.170370. PMID: 26752853; PMCID: PMC4691969.https://pubmed.ncbi.nlm.nih.gov/26752853/
Malhotra N, Shah D, Pai R, Pai HD, Bankar M. Assisted reproductive technology in India: A 3 year retrospective data analysis. J Hum Reprod Sci. 2013 Oct;6(4):235-40. doi: 10.4103/0974-1208.126286. PMID: 24672161; PMCID: PMC3963305.https://academic.oup.com/hropen/article/2017/2/hox011/4062213
Megan L. Sneed, Meike L. Uhler, H. Edward Grotjan, John J. Rapisarda, Kevin J. Lederer, Angeline N. Beltsos, Body mass index: impact on IVF success appears age-related , Human Reproduction, Volume 23, Issue 8, 1 August 2008, Pages 1835–1839, https://doi.org/10.1093/humrep/den188

Renowned MIT Professor Visits SpOvum TechnologiesJuly 20, 2024

SpOvum was invited to German delegation program at IIScApril 18, 2024

SpOvum featured in a newspaper article about Mane Hospital's LifeNu IVF centerAugust 2, 2023

Bulk stiffness and recovery time - a measure of development of mouse embryosAugust 2, 2023

SpOvum’s brief interaction with the Oasis teamNovember 29, 2022

RoboICSI is recognised at the Medicall Innovation awards 2021December 18, 2021

Introducing SpOvum’s ARTGPT™ Chatbot: Your 24/7 ART and Andrology ExpertSeptember 11, 2024

SpOvum at LifeNu

SpOvum has been operating successfully at Mane hospital’s LifeNU. While SpOvum is taking care of their operations including Technology-enablement, Embryologists, Dashboard, Maintenance, Calibration ad a bit of counseling. Recently SpOvum has also installed its flagship product- RoboICSI® holder, and smART Alerts system. SpOvum is making a conscious effort to see that LifeNU meets its KPIs along the Vienna consensus.

Largely, it has been successful in achieving so. For example, we have got an ICSI Damage rate of 0% (Benchmark from Vienna consensus is ≤ 5%), a Day3 Embryo Development rate of 84% (Benchmark from Vienna consensus is ≥ 70%), Blastocyst cryo survival rate of 100% (Benchmark from Vienna consensus is ≥ 99%)

SpOvum is making strides in ensuring IVF hospitals excel in providing quality IVF treatment to patients.

Renowned MIT Professor Visits SpOvum TechnologiesJuly 20, 2024

SpOvum was invited to German delegation program at IIScApril 18, 2024

SpOvum featured in a newspaper article about Mane Hospital's LifeNu IVF centerAugust 2, 2023

Bulk stiffness and recovery time - a measure of development of mouse embryosAugust 2, 2023

SpOvum’s brief interaction with the Oasis teamNovember 29, 2022

RoboICSI is recognised at the Medicall Innovation awards 2021December 18, 2021